Pathogens, the Microbiome, and Chronic Disease: Gathering Insight with Genomics
Many chronic diseases are thought to result from a combination of genomic factors, as well as environmental factors, such as diet, pathogen exposure, and dysbiosis. Certain genomic variations, called SNPs, may increase susceptibility to pathogens and dysbiosis, and may also increase the risk for a range of chronic diseases, including autoimmune and inflammatory diseases.
Advances in genomic technologies are helping clinicians to gain greater insight into each individual patient’s unique combination of SNPs. Such insight, in turn, holds great promise for facilitating the discovery of important underlying factors contributing to each patient’s unique health status, allowing more personalized approaches to treatment.
Additional Resources
- Please note: This is the second part of last month's webinar, Digestive Insufficiency, Dysbiosis, and Disease – Implications for Personalized Therapies.
- GI-MAP – GI Microbial Assay Plus
Author Tom Fabian, Ph.D., CNTP
Dr. Fabian is a leading expert on the role of the microbiome in health, immune function, chronic disease, and aging. As a translational scientist, his primary focus is on the clinical application of microbiome research in the integrative and functional medicine space. He received his PhD in molecular biology from the University of Colorado, Boulder, and has worked as a biomedical researcher in the biotechnology industry...
The opinions expressed in this presentation are the author's own. Information is provided for informational purposes only and is not meant to be a substitute for personal advice provided by a doctor or other qualified health care professional. Patients should not use the information contained herein for diagnosing a health or fitness problem or disease. Patients should always consult with a doctor or other health care professional for medical advice or information about diagnosis and treatment.